Stay updated on Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial
Sign up to get notified when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.

Latest updates to the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page
- Check7 days agoChange DetectedThe study record was updated with new post and submission dates (Last Update Posted 2026-03-05; 2026-03-04) to reflect recent edits to the trial details.SummaryDifference0.1%

- Check14 days agoChange DetectedStudy record updates were made on 2026-02-24 and 2026-02-25, refining the study details and related sections (timelines, locations, and eligibility/plan descriptions).SummaryDifference0.2%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check37 days agoChange DetectedA site-wide funding lapse notice was added, informing users that information may not be up to date and that the NIH Clinical Center is open, and the page now shows a revision update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check44 days agoChange DetectedA glossary toggle was added to the page. Capitalization updates were made to labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the revision tag was updated to v3.4.0.SummaryDifference0.2%

- Check58 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 (Revision: v3.3.4 added; v3.3.3 removed). No substantive content or functionality of the study page is affected.SummaryDifference0.0%

Stay in the know with updates to Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.